taurohyodeoxycholic acid has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, W; Cao, Y; Chen, Z; Hao, J; He, J; Heng, Z; Luo, X; Lv, L; Meng, C; Wang, L; Wang, X | 1 |
| He, J; Liang, J; Sun, W; Zhang, Y; Zhao, W; Zhu, S | 1 |
2 other study(ies) available for taurohyodeoxycholic acid and Colitis Gravis
| Article | Year |
|---|---|
Taurohyodeoxycholic acid alleviates trinitrobenzene sulfonic acid induced ulcerative colitis via regulating Th1/Th2 and Th17/Treg cells balance.
Topics: Animals; Colitis; Colitis, Ulcerative; Cytokines; Forkhead Transcription Factors; Interleukin-10; Interleukin-17; Interleukin-4; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid | 2023 |
Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice.
Topics: Animals; Body Weight; Colitis, Ulcerative; Colon; Drugs, Chinese Herbal; Gene Expression Regulation; Male; Mice; Peroxidase; Taurodeoxycholic Acid; Trinitrobenzenesulfonic Acid | 2011 |